ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Hormonal Therapy Improves Prostate Cancer Survival

August 27, 2004

In Brief: Coalition Begins Campaign To Educate Public

February 3, 1995

NIH Proposes Center for Cell Biology

February 19, 1993

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

Groups Advise NCI On “Investment Opportunities”

June 28, 1996

Healy Confirmed As NIH Director; States Priorities

April 5, 1991